MedTrace Logo

The ArtixASCEND Study

NCT07135895 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-05-11

No results posted yet for this study

Summary

This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.

Conditions

  • Acute Lower Limb Arterial Occlusion

Interventions

DEVICE

Artix Thrombectomy System

Treatment of lower extremity arterial occlusions using the Artix Thrombectomy System.

Sponsors & Collaborators

  • Inari Medical

    lead INDUSTRY

Principal Investigators

  • Scott T Lewis · Inari Medical

  • Anahita Dua, MD · Massachusetts General Hospital

  • Shang Loh, MD · Penn Presbyterian Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-07
Primary Completion
2029-03-01
Completion
2029-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07135895 on ClinicalTrials.gov